诚意药业10月28日龙虎榜数据

Core Viewpoint - Chengyi Pharmaceutical (603811) experienced a significant decline of 8.39% in its stock price, with a trading volume of 3.87 billion yuan and a turnover rate of 9.61% on the day of the report [2][3]. Trading Activity - The stock was listed on the Shanghai Stock Exchange's "龙虎榜" due to a daily price deviation of -8.17%, with institutional investors net selling 12.96 million yuan [2]. - The top five trading departments had a total transaction amount of 93.75 million yuan, with buying transactions amounting to 27.34 million yuan and selling transactions totaling 66.41 million yuan, resulting in a net sell of 39.07 million yuan [2][3]. - Among the trading departments, one institutional seat was noted, which was the second-largest seller, net selling 12.96 million yuan [2]. Recent Performance - Over the past six months, the stock has appeared on the "龙虎榜" five times, with an average price drop of 0.56% the day after being listed and an average decline of 2.62% over the following five days [3]. - On the day of the report, the stock saw a net inflow of 742,800 yuan from major funds, with a significant inflow of 12.62 million yuan from large orders, while large orders saw a net outflow of 11.88 million yuan [3]. Financial Results - The company reported its third-quarter results on October 28, showing a total revenue of 597 million yuan for the first three quarters, representing a year-on-year growth of 14.69%, and a net profit of 143 million yuan, reflecting a year-on-year increase of 21.91% [3].